Safety and efficacy of galactogogues: Substances that induce, maintain and increase breast milk production

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 13, Issue 2, 2010, Pages 162-174

  Zuppa, Antonio Alberto ^a   Sindico, Paola ^a   Orchi, Claudia ^a   Carducci, Chiara ^a   Cardiello, Valentina ^a   Romagnoli, Costantino ^a   Catenazzi, Piero ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DOMPERIDONE; GALACTOGOGUE; HERBACEOUS AGENT; MEDROXYPROGESTERONE; METOCLOPRAMIDE; OXYTOCIN; PHYTOESTROGEN; PLACEBO; PROTIRELIN; RECOMBINANT GROWTH HORMONE; SILYMARIN; SULPIRIDE;

ABSENCE OF SIDE EFFECTS; AMENORRHEA; ANXIETY; ASTHMA; BREAST FEEDING; DEPRESSION; DIAPHORESIS; DIARRHEA; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MILK LEVEL; DRUG SAFETY; DRUG USE; ENTEROPATHY; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FENUGREEK; GALEGA; GASTROINTESTINAL DISEASE; HUMAN; HYPERTHYROIDISM; HYPOGLYCEMIA; INSOMNIA; LACTATION; MILK PRODUCTION; NERVOUSNESS; PREMATURE LABOR; PRESCRIPTION; PRURITUS; PSYCHOSIS; RECOMMENDED DRUG DOSE; REVIEW; SCHIZOPHRENIA; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; SWEATING; XEROSTOMIA;

EID: 78650409232     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3ds3r     Document Type: Review

References (85)

1. Breastfeeding and the use of human milk. American Academy of Pediatrics.Work group on Breastfeeding. Pediatrics. 1997;100(6):1035-1039.
2. Canadian Paediatric Society Clinical Practice Guidelines Nutrition for healthy term infants: A joint statement of the Canadian Pediatric Society, dietitians of Canada and health Canada. Paediatr Child Health. 1998;3 (2):109-116
3. Chatterton RT, Hill PD, Aldag JC, Belknap SM, Jinman MJ. Relation of plasma oxytocin and PRL concentrations to milk production in mothers of preterm infants: influence of stress. J Clin Endocrinol Metab. 2000; 85(10):3661-3668.
4. Ehrenkranz RA, Ackerman BA. Metoclopramide effect on faltering milk production by mothers of premature infants. Pediatrics. 1986;78:614-620.
5. Sjölin S, Hofvander Y, Hillervik C. Factors related to early termination of breast feeding. A retrospective study in Sweden. Acta Paediatr Scand. 1977;66(4):505-511.
6. Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs. 1982;24(5):360-400.
7. Cox DB, Owens RA, Hartmann PE. Blood and milk prolactin and the rate of milk syntesis in women. Exp Phisiol. 1996; 81: 1007-20
8. Zuppa AA, Tornesello A, Papacci P, Tortorolo G, Segni G, Lafuenti G, Moneta E, Diodato A, Sorcini M, Carta S. Relationship between maternal parity, basal prolactin levels and neonatal breast milk intake. Biol neonate 1988; 53:144-7.
9. Campbell-Yeo ML, Allen AC, Joseph KS, Ledwidge JM, Allen VM, Dooley KC. Study protocol: a double blind placebo controlled trial examining the effect of domperidone on the composition of breast milk. BMC Pregnancy and Childbirth. 2006; 6:17.
10. De Gezelle H, Ooghe W, Thiery M, Dhont M. Metoclopramide and breast milk. Eur J Obstet Gynecol Reprod Biol. 1983;15(1):31-36.
11. Biervliet FP, Maguiness SD, Hay DM, Killick SR, Atkin SL. Induction of lactation in the intended mother of a surrogate pregnancy: Case report. Hum Reprod. 2001;16:581-583.
12. Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs. 1982;24(5):360-400.
13. Cheales-Siebenaler NJ. Induced lactation in an adoptive mother. J Hum Lact. 1999;15:41-43.
14. Ertl T, Sulyok E, Ezer E, Sárkány I, Thurzó V, Csaba IF. The influence of metoclopramide on the composition of human breast milk. Acta Paediatr Hung. 1991;31:415-422.
15. Gupta AP, Gupta PK. Metoclopramide as a lactogogue. Clin Pediatr (Phila). 1985;24:269-272.
16. Guzmán V, Toscano G, Canales ES, Zárate A. Improvement of defective lactation by using oral metoclopramide. Acta Obstet Gynecol Scand. 1979;58:53-55.
17. Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, Heel RC. Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs. 1983;25:451-494.
18. Kauppila A, Anunti P, Kivinen S, Koivisto M, Ruokonen A. Metoclopramide and breast feeding: efficacy and anterior pituitary responses of the mother and the child. Eur J Obstet Gynecol Reprod Biol. 1985;19:19-22.
19. Kauppila A, Arvela P, Koivisto M, Kivinen S, Ylikorkala O, Pelkonen O. Metoclopramide and breast feeding: transfer into milk and the newborn. Eur J Clin Pharmacol. 1983;25:819-823.
20. Kauppila A, Kivinen S, Ylikorkala O. A dose response relation between improved lactation and metoclopramide. Lancet. 1981;1(8231):1175-1177.
21. Kauppila A, Kivinen S, Ylikorkala O. Metoclopramide increases PRL release and milk secretion in puerperium without stimulating the secretion of thyrotropin and thyroid hormones. J Clin Endocrinol Metab. 1981;52:436-439.
22. Sousa PLR. Metoclopramide and Breast-feeding. Br Med J. 1975;1:512.
23. Toppare MF, Laleli Y, Senses DA, Kitaper F, Kaya IS, Dilmen U. Metoclopramide for breast milk production. Nutrition Res. 1994;14:1019-1029
24. Lewis PJ, Devenish C, Kahn C. Controlled trial of metoclopramide in the initiation of breast feeding. Br J Clin Pharmacol. 1980;9:217-219.
25. Hansen WF, McAndrew S, Harris K, Zimmerman MB. Metoclopramide effect on breastfeeding the preterm infant: a randomized trial. Obstet Gynecol. 2005;105(2):383-389.
26. Sankaran K, Yeboah E, Bingham WT, Ninan A. Use of metoclopramide in preterm infants. Dev Pharmacol Ther. 1982;5:114-119.
27. Hallbauer U. Sulpiride (Egonyl)- use to stimulate lactation. S Afr Med J. 1997;87:774-775.
28. Hampton T. FDA warns against breast milk drug. JAMA. 2004;292:322.
29. Hannon PR, Duggan AK, Serwint JR, Vogelhut JW, Witter F, De Angelis C. The influence of medroxyprogesterone on the duration of breastfeeding in mothers in an urban community. Arch Pediatr Adolesc Med. 1997;15, 151:490-496.
30. Heykants J, Hendriks R, Meuldermans W, Michiels M, Scheygrond H, Reyntjens H. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration. Eur J Drug Metab Pharmacokinet. 1981;6:61-70.
31. Hofmeyer GJ, Van Iddekinge. Domperidone and lactation. Lancet.1983;1:647.
32. Hofmeyer GJ, Van Iddekinge B, Blott JA. Domperidone: secretion in breast milk and effect on puerperal PRL levels. Br J Obstet Gynaecol. 1985;92(2):141-144.
33. Joss RA, Goldhirsch A, Brunner KW, Galeazzi RL. Sudden death in cancer patient on high-dose domperidone. Lancet. 1982;1:1019.
34. Karim M, Ammar R, El Mahgoub S, Ganzoury B, Fikri F, Abdou Z. Injected proesterone and lactation. Br Med J. 1971;1:200-203.
35. Lewis JH, Weingold AB. The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol. 1985;80:912-923.
36. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human breast milk. Pediatrics. 2001;108:776-789.
37. Briggs GG, Freeman RK, Yaffe SJ, eds. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk with access code. New York: Lippincott Williams& Wilkins; 2006.
38. Delaloye J-F, De Grandi P, Vial Y, Hohlfeld P. Médicaments grossesse et lactation. Médecine & Hygiène, Département livre Georg 46, Chemin de la Mousse, 1225 Chêne-Bourg (Souisse). 1997.
39. Barone JA. Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother. 1999;33:429-440.
40. Da Silva OP, Knoppert DC, Angelini MM, Forret PA. Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. CMAJ. 2001;164:17-21.
41. Petraglia F, De Leo V, Sardelli S, Pieroni ML, D'Antona N, Genazzani AR. Domperidone in defective and insufficient lactation. Eur J Obstet Gynecol Reprod Biol. 1985;19:281-287.
42. FDA cautions breast-feeding moms. FDA Consum. 2004;38:6.
43. Da Silva OP, Knoppert DC. Domperidone for lactating women. CMAJ. 2004 28;171:725-726.
44. Gabay MP, Pharm D, BCPS. Galactogogues: Medications that induce lactation. J Hum Lact. 2002;18:274-279.
45. Bryant CA. Nursing the adopted infant. J Am Board Fam Med. 2006;19:374-379.
46. Giaccone G, Bertetto O, Calciati A. Two sudden deaths during prophylactic antiemetic treatment with high doses of domperidone and methylprednisolone. Lancet.1984;2:1336 -1337.
47. Osborne RJ, Slevin ML, Hunter RW, Hamer J. Cardiotoxicity of intravenous domperidone. Lancet. 1985;2:385.
48. Roussak JB, Carey P, Parry H. Cardiac arrest after treatment with intravenous domperidone. Br Med J. 1984;289:1579.
49. Weichert CE. Lactational reflex recovery in breast-feeding failure. Pediatrics. 1979;63:799-803.
50. Blacker KH, Weinstein BJ, Ellman GL. Mothers milk and chlorpromazine. Am J Psychol. 1962;114:178-179.
51. Wiles DH, Orr MW, Kolakovska T. Chlorpromazine levels in plasma and milk of nursing mothers. Pr J Clin Pharmacol. 1978;5:272-273.
52. Yoshida K, Smith B, Craggs M, Kumar R. Neuroepileptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol Med. 1998;28:81-91.
53. Gentile S. Infant safety with antipsychotic therapy in breast-feeding:a systematic review. J Clin Psychiatry. 2008;69:666-673.
54. Aono T, Shoioji T, Aki T, Hirota K, Nomura A, Kurachi K. Augmentation of puerperal lactation by oral administration of sulpiride. J Clin Endocrinol Metab. 1979;48:478-82.
55. Mancini AM, Guitelman A, Vargas CA, Debeljuk L and Aparicio NJ. Effect of sulpiride on serum PRL levels in humans. Clin Endocrinol Metab. 1976;42:181-184.
56. Ylikorkala O, Kauppila A, Kivinen S, Viinikka L. Sulpiride improve inadeguate lactation. Br Med J (Clin Res Ed). 1982;285:249-251.
57. Polatti F. Sulpiride isomers and milk secretion in puerperium. Clin Exp Obstet Gynecol. 1982;9:144-147.
58. Aono T, Aki T, Koike K, Kurachi K. Effect of Sulpiride on poor puerperal lactation. Am J Obstet Gynecol. 1982;143:927-932.
59. Ylikorkala O, Kauppila A, Kivinen S, Viinikka L. Treatment of inadequate lactation with oral sulpiride and buccal oxytocin. Obstet Gynecol. 1984;63:57-60.
60. Bazire S. Psychotropic Drug Directory. Salisbury, UK: Fivepin Publishing, 2003/04: 209-216.
61. Renfrew MJ, Lang S, Woolridge M. Oxytocin for promoting successful lactation. Cochrane Database Syst Rev. 2000;(2):CD000156. Review.
62. Ruis H, Rolland R, Doesburg W, Broeders G, Corbey R. Oxytocin enhances onset of lactation among mothers delivering prematurely.Br Med J (Clin Res Ed). 1981;283:340-342.
63. Fewtrell MS, Loh KL, Blake A, Ridout DA, Hawdon J. Randomised, double blind trial of oxytocin nasal spray in mothers expressing breast milk for preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006; 91: 169-174.
64. Trott JF, Vonderhaar BK, Hovey RC. Historical perspectives of PRL and growth hormone as mammogens, lactogens and galactagogues-agog for the future! J Mammary Gland Biol Neoplasia. 2008;13:3-11.
65. Breier BH, Milsom SR, Blum WF, Schwander J, Gallaher BW, Gluckman PD. Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women. Acta Endocrinol (Copenh). 1993;129:427-435.
66. Milsom SR, Breier BH, Gallaher BW, Cox VA, Gunn AJ, Gluckman PD. Growth hormone stimulates galactopoiesis in healthy lactating women. Acta Endocrinol (Copenh). 1992;127:337-343.
67. Gunn AJ, Gunn TR, Rabone DL, Breier BH, Blum WF, Gluckman PD. Growth hormone increases breast milk volumes in mothers of preterm infants. Pediatrics. 1996;98:279-282.
68. Milsom SR, Rabone DL, Gunn AJ, Gluckman PD. Potential role for growth hormone in human lactation insufficiency. Horm Res. 1998;50:147-150.
69. Kivinen S, Kauppila A, Ylikorkala O, Puukka M. Effect of oral thyrotrophin releasing hormone on serum PRL, thyrotropin and total thyroxine levels in postpartum women. Z Geburtshilfe Perinatol. 1978 Apr;182:113-116.
70. Tyson JE, Perez A, Zanartu J. Human lactational response to oral thyrotropin releasing hormone. J Clin Endocrinol Metab. 1976;43:760-776.
71. Zarate A, Villalobos H, Canales ES, Soria L, Arcovedo F, MacGregor C. The effect of oral administration of thyrotropin-releasing hormone on lactation. J Clin Endocrinol Metab. 1976;43:301-305.
72. Ylikorkala O, Kivinen S., Kauppila A. Oral administration of TRH in puerperal women: effect on insufficient lactation, thyroid hormones and on the responses of TSH and PRL to intravenous TRH. Acta Endocrinol (Copenh). 1980;93(4):413-418
73. Bose CL, D'Ercole J, Lester AG, Hunter RS, Barret JR. Relactation by mothers of sick or premature infants. Pediatrics. 1981;67:565-569.
74. Peters F, Schulze-Tollert J, Schuth W. Thyrotrophin-releasing hormone: a lactationpromoting agent? Br J Obstet Gynaecol. 1991;98:880-885.
75. Guiloff E, Ibarra-Polo A, Zanartu J, Toscanini C, Mischler TW, Gomez-Rogers C. Effects of contraception on lactation. Am J Obstet Gynecol. 1974;118:42-45.
76. Saxena BN, Shrimanker K, Grudzinskas JG. Levels of contraceptive steroids in breast milk and plasma of lactating women. Contraception. 1977 Dec;16(6):605-613.
77. Kelsey JJ. Hormonal contraception and lactation. J Hum Lact. 1996;12:315-318.
78. Swafford S, Berens P. Effect of fenugreek on breast milk production. Abstract 5th International Meeting of the Academy of Breastfeeding Medicine September 11-13, 2000, Tucson, Ariz Academy of Breastfeeding Medicine News and Views 2000;6(3).
79. Caroline J, Chantry MD. The academy of breastfeeding medicine protocol committee. Protocol n°9: Use of galactogogues in initiating or augmenting maternal milk supply. 2004.
80. Rosti L, Nardini A, Bettinelli ME, Rosti D. Toxic effect of an herbal tea mixture in two newborns. Acta Pediatr.1994;83:683
81. Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006;124:491-504.
82. Carotenuto D, Di Pierro F. Studio sulla tollerabilità ed efficaciadella silimarina BIO-C ® (Piùlatte ®) micronizzata come galattagogo. Acta Neonatologica & Pediatrica. 2005;4:393-40.
83. Vojtisek B. Milk Thistel (silybum marianum) in the feed of ketotik cow. Veterinary Medicine. 1991.
84. Kren V, Walterova D. Silybin and Silymarin - new effects and applications. Biomed. Papers. 2005;149:29-41.
85. Gallo D, Giacomelli S, Ferlini C, Raspaglio G, Apollonio P, Prislei S, Riva A, Morazzoni P, Bombardelli E, Scambia G. Antitumor activity of the silybin- phosphatidylcholine complex, IdB 1016, against human ovarian cancer. Eur J Cancer.2003;39:2403-2410.